Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N6YV
|
||||
| Former ID |
DIB012782
|
||||
| Drug Name |
Cenestin
|
||||
| Synonyms |
Synthetic conjugated estrogens-A, Barr; Synthetic conjugated estrogens-A, Duramed
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Menopause symptoms [ICD10:N95.0] | Approved | [551871] | ||
| Company |
Duramed Pharmaceuticals Inc
|
||||
| Formula |
C18H19NaO5S
|
||||
| Canonical SMILES |
[Na+].O=S(=O)(Oc1cc2c([C@@H]3[C@H]([C@H]4[C@](CC3)(C(=O<br />)CC4)C)CC2)cc1)[O-].[Na+].O=S(=O)(Oc1cc2c([C@@H]3C(=CC2<br />)[C@H]2[C@](CC3)(C(=O)CC2)C)cc1)[O-]
|
||||
| CAS Number |
CAS 12126-59-9
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Agonist | [526290], [551871] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.